Victory Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.31M | Sell |
336,804
-202,978
| -38% | -$4.4M | ﹤0.01% | 1201 |
|
|
2025
Q1 | $13.1M | Buy |
539,782
+243,702
| +82% | +$5.91M | 0.01% | 955 |
|
|
2024
Q4 | $6.18M | Buy |
296,080
+4,575
| +2% | +$95.5K | 0.01% | 1216 |
|
|
2024
Q3 | $5.8M | Buy |
291,505
+15,996
| +6% | +$318K | 0.01% | 1244 |
|
|
2024
Q2 | $4.27M | Sell |
275,509
-3,281
| -1% | -$50.8K | ﹤0.01% | 1272 |
|
|
2024
Q1 | $4.44M | Buy |
278,790
+21,067
| +8% | +$336K | ﹤0.01% | 1264 |
|
|
2023
Q4 | $4.33M | Sell |
257,723
-53,632
| -17% | -$902K | ﹤0.01% | 1261 |
|
|
2023
Q3 | $3.64M | Buy |
311,355
+17,697
| +6% | +$207K | ﹤0.01% | 1266 |
|
|
2023
Q2 | $3.95M | Buy |
293,658
+4,709
| +2% | +$63.3K | ﹤0.01% | 1243 |
|
|
2023
Q1 | $4.79M | Sell |
288,949
-3,977
| -1% | -$65.9K | 0.01% | 1206 |
|
|
2022
Q4 | $5.45M | Sell |
292,926
-73,066
| -20% | -$1.36M | 0.01% | 1185 |
|
|
2022
Q3 | $4.7M | Buy |
365,992
+670
| +0.2% | +$8.6K | 0.01% | 1260 |
|
|
2022
Q2 | $2.56M | Sell |
365,322
-14,884
| -4% | -$104K | ﹤0.01% | 1402 |
|
|
2022
Q1 | $3.04M | Buy |
380,206
+271,172
| +249% | +$2.17M | ﹤0.01% | 1373 |
|
|
2021
Q4 | $739K | Sell |
109,034
-37,297
| -25% | -$253K | ﹤0.01% | 1968 |
|
|
2021
Q3 | $775K | Sell |
146,331
-46,249
| -24% | -$245K | ﹤0.01% | 1961 |
|
|
2021
Q2 | $1.11M | Sell |
192,580
-9,890
| -5% | -$56.9K | ﹤0.01% | 1861 |
|
|
2021
Q1 | $933K | Buy |
202,470
+59,611
| +42% | +$275K | ﹤0.01% | 1946 |
|
|
2020
Q4 | $477K | Buy |
142,859
+30,811
| +27% | +$103K | ﹤0.01% | 2107 |
|
|
2020
Q3 | $333K | Buy |
112,048
+23,614
| +27% | +$70.2K | ﹤0.01% | 2124 |
|
|
2020
Q2 | $409K | Sell |
88,434
-72,986
| -45% | -$338K | ﹤0.01% | 2052 |
|
|
2020
Q1 | $622K | Buy |
161,420
+94,787
| +142% | +$365K | ﹤0.01% | 2014 |
|
|
2019
Q4 | $250K | Buy |
66,633
+23,929
| +56% | +$89.8K | ﹤0.01% | 2257 |
|
|
2019
Q3 | $227K | Buy |
+42,704
| New | +$227K | ﹤0.01% | 2179 |
|